These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29977893)

  • 1. Peak MSC-Are We There Yet?
    Olsen TR; Ng KS; Lock LT; Ahsan T; Rowley JA
    Front Med (Lausanne); 2018; 5():178. PubMed ID: 29977893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.
    Guadix JA; López-Beas J; Clares B; Soriano-Ruiz JL; Zugaza JL; Gálvez-Martín P
    Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31652984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corporate profile: RoosterBio, Inc.
    Olsen TR; Rowley JA
    Regen Med; 2018 Oct; 13(7):753-757. PubMed ID: 30289343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing.
    Jayaraman P; Lim R; Ng J; Vemuri MC
    Front Cell Dev Biol; 2021; 9():648472. PubMed ID: 33928083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process.
    Heathman TR; Glyn VA; Picken A; Rafiq QA; Coopman K; Nienow AW; Kara B; Hewitt CJ
    Biotechnol Bioeng; 2015 Aug; 112(8):1696-707. PubMed ID: 25727395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review.
    Panchalingam KM; Jung S; Rosenberg L; Behie LA
    Stem Cell Res Ther; 2015 Nov; 6():225. PubMed ID: 26597928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of multicellular aggregate by E-cadherin coated microparticles enhancing the hepatic specific differentiation of mesenchymal stem cells.
    Cao L; Zhang Y; Qian M; Wang X; Shuai Q; Gao C; Lang R; Yang J
    Acta Biomater; 2019 Sep; 95():382-394. PubMed ID: 30660779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at U.S. academic centers.
    Phinney DG; Galipeau J;
    Cytotherapy; 2019 Jul; 21(7):782-792. PubMed ID: 31182333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy.
    Turinetto V; Vitale E; Giachino C
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free process development: improving the yield and consistency of human mesenchymal stromal cell production.
    Heathman TR; Stolzing A; Fabian C; Rafiq QA; Coopman K; Nienow AW; Kara B; Hewitt CJ
    Cytotherapy; 2015 Nov; 17(11):1524-35. PubMed ID: 26432558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
    Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM
    Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biobanking of Human Mesenchymal Stem Cells: Future Strategy to Facilitate Clinical Applications.
    Yong KW; Choi JR; Wan Safwani WK
    Adv Exp Med Biol; 2016; 951():99-110. PubMed ID: 27837557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consensus introduction to serum replacements and serum-free media for cellular therapies.
    Karnieli O; Friedner OM; Allickson JG; Zhang N; Jung S; Fiorentini D; Abraham E; Eaker SS; Yong TK; Chan A; Griffiths S; Wehn AK; Oh S; Karnieli O
    Cytotherapy; 2017 Feb; 19(2):155-169. PubMed ID: 28017599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production via good manufacturing practice of exofucosylated human mesenchymal stromal cells for clinical applications.
    López-Lucas MD; Pachón-Peña G; García-Hernández AM; Parrado A; Sánchez-Salinas D; García-Bernal D; Algueró MDC; Martinez FI; Blanquer M; Cabañas-Perianes V; Molina-Molina M; Asín-Aguilar C; Moraleda JM; Sackstein R
    Cytotherapy; 2018 Sep; 20(9):1110-1123. PubMed ID: 30170815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates.
    Bianchi F; Maioli M; Leonardi E; Olivi E; Pasquinelli G; Valente S; Mendez AJ; Ricordi C; Raffaini M; Tremolada C; Ventura C
    Cell Transplant; 2013; 22(11):2063-77. PubMed ID: 23051701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy?
    Yuan X; Logan TM; Ma T
    Front Immunol; 2019; 10():977. PubMed ID: 31139179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells].
    Sawada R; Ito T; Tsuchiya T
    Yakugaku Zasshi; 2007 May; 127(5):851-6. PubMed ID: 17473528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling mesenchymal stromal cell immunomodulatory analysis using scalable platforms.
    Williams EK; García JR; Mannino RG; Schneider RS; Lam WA; García AJ
    Integr Biol (Camb); 2019 Apr; 11(4):154-162. PubMed ID: 31135880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
    Warnke PH; Humpe A; Strunk D; Stephens S; Warnke F; Wiltfang J; Schallmoser K; Alamein M; Bourke R; Heiner P; Liu Q
    J Craniomaxillofac Surg; 2013 Mar; 41(2):153-61. PubMed ID: 22878221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.